Copertina

More rTMS pulses or more sessions? The impact on treatment outcome for treatment resistant depression

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	E. Oostra, P. Jazdzyk, V. Vis, I. Dalhuisen, A. W. Hoogendoorn, C. H. M. Planting, P. F. van Eijndhoven, Y. D. van der Werf, O. A. van den Heuvel, E. van Exel
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Acta Psychiatrica Scandinavica
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cost‐Effectiveness of rTMS as a Next Step in Antidepressant Non‐Responders: A Randomized Comparison With Current Antidepressant Treatment Approaches
di: Iris Dalhuisen, et al.
Pubblicazione: (2024)

Repetitive Transcranial Magnetic Stimulation ( rTMS ) for Adolescent Depression: A Systematic Review and Meta‐Analysis of Treatment Response and Suicidal Ideation Reduction
di: Lidija Rakic, et al.
Pubblicazione: (2026)

The Effect of Benzodiazepines on Catatonia: A Systematic Review and Meta‐Analysis
di: L. Bot, et al.
Pubblicazione: (2026)

Can ECT and rTMS Finally Help Us Trust in Precision Psychiatry?
di: Robert M. Lundin
Pubblicazione: (2025)

Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations
di: Yuanjun Xie, et al.
Pubblicazione: (2025)

The conversation about family planning and desire for children in mental healthcare: Patients' perspective versus Professionals' perspective in a mixed methods study
di: Noralie N. Schonewille, et al.
Pubblicazione: (2024)

Psychosis Prognosis Predictor: A continuous and uncertainty‐aware prediction of treatment outcome in first‐episode psychosis
di: Daniël P. J. van Opstal, et al.
Pubblicazione: (2024)

Monoamine oxidase inhibitors: Seriously underused in the treatment of major depression
di: Tom K. Birkenhager, et al.
Pubblicazione: (2024)

Monoamine oxidase inhibitors in depression treatment: Addressing gaps and future directions
di: Jen‐Chin Lee, et al.
Pubblicazione: (2024)

Not all types of depressed patients who persist with their antidepressant treatment improve in side effect complaints: A comparison of treatment completers and dropouts in the STAR *D trial
di: Thomas T. Kim, et al.
Pubblicazione: (2024)

Confusional States During Electroconvulsive Therapy for Late‐Life Depression: A Prospective Cohort Study
di: Thomas C. Feenstra, et al.
Pubblicazione: (2025)

Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta‐analysis
di: Anna Giménez‐Palomo, et al.
Pubblicazione: (2024)

Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis
di: M. Berkhof, et al.
Pubblicazione: (2024)

Dose response relationship between lithium serum levels during pregnancy and birth outcomes
di: Lisanne Schrijver, et al.
Pubblicazione: (2024)

Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression
di: Ahmed Al‐Wandi, et al.
Pubblicazione: (2024)

Linguistic style as a digital marker for depression severity: An ambulatory assessment pilot study in patients with depressive disorder undergoing sleep deprivation therapy
di: Lisa‐Marie Hartnagel, et al.
Pubblicazione: (2024)

Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment‐resistant schizophrenia
di: Marisa Bezerra de Araujo, et al.
Pubblicazione: (2024)

Childhood maltreatment and outcomes following electroconvulsive therapy in adults with depression
di: Ana Jelovac, et al.
Pubblicazione: (2024)

Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety
di: Jonne Lintunen, et al.
Pubblicazione: (2024)

Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach
di: Julia Eder, et al.
Pubblicazione: (2024)

Is a vegetarian diet beneficial for bipolar disorder? Relationship between dietary patterns, exercise and pharmacological treatments with metabolic syndrome and course of disease in bipolar disorder
di: Susana Gomes‐da‐Costa, et al.
Pubblicazione: (2024)

Exploring actigraphy as a digital phenotyping measure: A study on differentiating psychomotor agitation and retardation in depression
di: Julia Maruani, et al.
Pubblicazione: (2024)

Digital nature: Unveiling the impact and safety of FlowVR group intervention for depression in a feasibility trial
di: Franziska Miegel, et al.
Pubblicazione: (2024)

Bidirectional associations between perinatal allopregnanolone and depression severity with postpartum gray matter volume in adult women
di: Megan M. Hare, et al.
Pubblicazione: (2024)

Interrelationships of Changes in Outcome Domains in Patients With Schizophrenia Spectrum Disorders: A Meta‐Analysis
di: Lars de Winter, et al.
Pubblicazione: (2025)

Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26‐week open‐label feasibility study
di: Marie Reeberg Sass, et al.
Pubblicazione: (2024)

Augmentation with prazosin for patients with depression and a history of trauma: A randomised, double‐blind, placebo‐controlled study
di: Ping Guo, et al.
Pubblicazione: (2024)

Association Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross‐Sectional and Longitudinal Analyses in the FACE ‐ BD Cohort
di: I. Palimaru, et al.
Pubblicazione: (2025)

Response to the letter to the Editor from Araujo and colleagues on the research article entitled, “Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study”
di: Masaru Tsukahara, et al.
Pubblicazione: (2024)

Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2‐year long‐term nation‐wide population‐based study emulating a randomized trial
di: Lars Vedel Kessing, et al.
Pubblicazione: (2024)

Evidence of a Widening Mortality Gap for People With Schizophrenia Spectrum Disorders: Implications for Early Intervention Services
di: Alexis E. Cullen
Pubblicazione: (2025)

Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi‐national EU ‐ GEI study
di: Giuseppe D'Andrea, et al.
Pubblicazione: (2024)

A national evaluation of a multi‐modal, blended, digital intervention integrated within Australian youth mental health services
di: M. Alvarez‐Jimenez, et al.
Pubblicazione: (2024)

Childhood Maltreatment and Biomarkers in Neuropsychiatric Disorders
di: Natalia E. Fares‐Otero, et al.
Pubblicazione: (2026)

Cognition Assessment in Virtual Reality ( CAVIR )—English Version: Validation of a Novel Virtual Reality Test for Daily Life Cognitive Functions in Patients With Affective Disorders
di: Kathryn E. Lewandowski, et al.
Pubblicazione: (2026)

Systematic Multi‐Trait Study of Genetic Correlation and Causality Relationships Between General Medical Conditions and Mental Disorders
di: Ron Nudel, et al.
Pubblicazione: (2025)

Family History and Solar Insolation in Bipolar I Disorder
di: M. Bauer, et al.
Pubblicazione: (2026)

Recovery and Recurrence From Major Depression in Adolescence and Adulthood
di: Adrian E. Desai Boström, et al.
Pubblicazione: (2025)

Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse Study
di: B. Solé, et al.
Pubblicazione: (2025)

Digital phenotyping in bipolar disorder: Using longitudinal Fitbit data and personalized machine learning to predict mood symptomatology
di: Jessica M. Lipschitz, et al.
Pubblicazione: (2024)